Output Biosciences blog · Nov 2025
Company blog post arguing that drug discovery should move beyond single-target optimization toward system-level, multi-target biology and biologically-aware generative AI.
Teaching Generative AI the Language of Biology
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Output Biosciences is a New York-based biotechnology company building biologically-aware generative AI and large biological models for drug discovery and breakthrough medicines.
Primary product
Biologically-aware generative AI / Large Biological Models for drug discovery
Founded
2021
Headquarters
Union Square, New York, New York 10003, United States
Team size
1-10 employees
Work style
Flexible
Industry
Biotechnology Research
Sub-industry
AI drug discovery / computational biology
Offices
Business model
Stage
pre-seed
Total raised
$125K
Latest round
Pre-Seed · Aug 2021
Latest amount
$125K
Aug 2021 · Y Combinator
Investors
Mission-driven and stealth-mode, with messaging that emphasizes repeat founders, biotech veterans, and values of Heart, Excellence, Practicality, Honesty, and Fun.
Work style
Flexible
Visa sponsorship
Limited
Compensation
Public postings describe competitive salary and equity, with medical, dental, and vision coverage.
Benefits
Differentiators
Technology
Competitors
Estimated revenue
≈$440K annual revenue (estimated)
Estimated monthly visits
3K
Traffic estimate as of Jun 2026
Output Biosciences blog · Nov 2025
Company blog post arguing that drug discovery should move beyond single-target optimization toward system-level, multi-target biology and biologically-aware generative AI.
CB Insights · Mar 2024
CB Insights profile describes the company as preventative therapeutics focused on extending human healthspan, and identifies founders, funding, headquarters, and investors.
Built In
Current hiring post describing the company as stealth-mode, backed by Y Combinator, and using a biological reasoning model for AI-driven drug discovery.
Built In
Current hiring post showing the company is still recruiting and describing its preventative therapeutics mission and AI/biotech positioning.